129 related articles for article (PubMed ID: 37743541)
1. Managing molecular relapse of acute myeloid leukaemia in early pregnancy: Is a watch and wait approach reasonable?
Mahdi D; O'Nions J; Raj K; Baker R; Jarratt R; Williams D; Burt R
Br J Haematol; 2023 Dec; 203(5):e114-e116. PubMed ID: 37743541
[No Abstract] [Full Text] [Related]
2. Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia.
Tang FF; Xu LP; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Yan CH; Sun YQ; Mo XD; Liu KY; Huang XJ
Br J Haematol; 2018 Feb; 180(3):448-451. PubMed ID: 27650511
[No Abstract] [Full Text] [Related]
3. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
[No Abstract] [Full Text] [Related]
4. Tracing the origins of relapse in acute myeloid leukaemia to stem cells.
Shlush LI; Mitchell A; Heisler L; Abelson S; Ng SWK; Trotman-Grant A; Medeiros JJF; Rao-Bhatia A; Jaciw-Zurakowsky I; Marke R; McLeod JL; Doedens M; Bader G; Voisin V; Xu C; McPherson JD; Hudson TJ; Wang JCY; Minden MD; Dick JE
Nature; 2017 Jul; 547(7661):104-108. PubMed ID: 28658204
[TBL] [Abstract][Full Text] [Related]
5. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
6. Very Late Relapse in Pediatric Acute Myeloid Leukemia: A Case Report and Brief Literature Review.
Unis GD; VanderVeen N; Fletcher M; Vasquez RJ
J Pediatr Hematol Oncol; 2021 Aug; 43(6):236-239. PubMed ID: 33136777
[TBL] [Abstract][Full Text] [Related]
7. Molecular alterations in acute myeloid leukemia and their clinical and therapeutical implications.
Infante MS; Piris MÁ; Hernández-Rivas JÁ
Med Clin (Barc); 2018 Nov; 151(9):362-367. PubMed ID: 29895422
[TBL] [Abstract][Full Text] [Related]
8. Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.
Cortes J; Perl AE; Döhner H; Kantarjian H; Martinelli G; Kovacsovics T; Rousselot P; Steffen B; Dombret H; Estey E; Strickland S; Altman JK; Baldus CD; Burnett A; Krämer A; Russell N; Shah NP; Smith CC; Wang ES; Ifrah N; Gammon G; Trone D; Lazzaretto D; Levis M
Lancet Oncol; 2018 Jul; 19(7):889-903. PubMed ID: 29859851
[TBL] [Abstract][Full Text] [Related]
9. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Döhner H; Weber D; Krzykalla J; Fiedler W; Kühn MWM; Schroeder T; Mayer K; Lübbert M; Wattad M; Götze K; Fransecky L; Koller E; Wulf G; Schleicher J; Ringhoffer M; Greil R; Hertenstein B; Krauter J; Martens UM; Nachbaur D; Samra MA; Machherndl-Spandl S; Basara N; Leis C; Schrade A; Kapp-Schwoerer S; Cocciardi S; Bullinger L; Thol F; Heuser M; Paschka P; Gaidzik VI; Saadati M; Benner A; Schlenk RF; Döhner K; Ganser A;
Lancet Haematol; 2023 Jul; 10(7):e495-e509. PubMed ID: 37187198
[TBL] [Abstract][Full Text] [Related]
10. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
11. AML: making residual disease more measurable.
Voso MT; Buccisano F
Blood; 2022 Aug; 140(5):415-417. PubMed ID: 35925646
[No Abstract] [Full Text] [Related]
12. Isocitrate dehydrogenase inhibitor-driven differentiation may resemble secondary graft failure in post-allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia.
Rasche A; Mason EF; Strickland SA; Byrne M; Ferrell PB
Br J Haematol; 2021 Sep; 194(5):927-931. PubMed ID: 34096047
[No Abstract] [Full Text] [Related]
13. Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.
Routledge DJM; Tower C; Davies E; Scott M; Waller M; Burthem J; Dignan FL
Br J Haematol; 2018 Feb; 180(4):605-606. PubMed ID: 27766620
[No Abstract] [Full Text] [Related]
14. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
[No Abstract] [Full Text] [Related]
15. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis.
Versluis J; Hazenberg CL; Passweg JR; van Putten WL; Maertens J; Biemond BJ; Theobald M; Graux C; Kuball J; Schouten HC; Pabst T; Löwenberg B; Ossenkoppele G; Vellenga E; Cornelissen JJ;
Lancet Haematol; 2015 Oct; 2(10):e427-36. PubMed ID: 26686044
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation.
Spencer Chapman M; Araf S; Smith M
J Clin Pathol; 2016 Mar; 69(3):275-6. PubMed ID: 26491143
[No Abstract] [Full Text] [Related]
17. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
[TBL] [Abstract][Full Text] [Related]
18. Optimising care for UK patients with acute myeloid leukaemia.
Pagliuca A; Khwaja A; Dillon R; Evans PA; Mohite U
Br J Hosp Med (Lond); 2022 Aug; 83(8):42-50. PubMed ID: 36066288
[TBL] [Abstract][Full Text] [Related]
19. Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia.
Fordham SE; Cole M; Irving JA; Allan JM
Leukemia; 2015 Feb; 29(2):491-4. PubMed ID: 25249014
[No Abstract] [Full Text] [Related]
20. Acute myeloid leukaemia.
Short NJ; Rytting ME; Cortes JE
Lancet; 2018 Aug; 392(10147):593-606. PubMed ID: 30078459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
